AMERICAN FORK, UT, Biolexis Therapeutics secures $10M Series A funding led by Clarke Capital.
Biolexis Therapeutics announced the closure of a $10 million Series A funding round led by Clarke Capital.
Biolexis Therapeutics is a clinical stage AI-driven drug discovery company. This funding will advance Biolexis' development pipeline which includes a range of promising metabolic drug candidates.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
